The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.

Dr. Simó has also recently pronounced the lecture of admission as a new member of the Royal Academy of Medicine of Catalonia.

The investment will enable D-Sight to progress with the first phase of clinical validation of their drug for early-stage diabetic retinopathy and glaucoma.

The Alberto Sols Award recognizes his contributions to diabetes research, including the description of the mechanisms of neurodegeneration in diabetic retinopathy, as well as new therapeutic strategies and early neuroprotective pathways.

A study involving the Vall d'Hebron Research Institute (VHIR) shows that moderate and high caffeine consumption is associated with a 65% reduction of the risk of suffering diabetic retinopathy in people with type 2 diabetes.

The recognition means the admission of the current head of the Endocrinology and Nutrition Service of Vall d'Hebron University Hospital and of the Diabetes and Metabolism research group of VHIR as a member of the RAMC.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

En les consultes de la Unitat de Tractament Integral de l’Obesitat de Vall d’Hebron els avenços de la recerca estan molt presents, ja sigui en forma d’assaig clínic o mitjançant la utilització d’unes ulleres de realitat virtual.

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The head of the Medical Molecular Imaging group at VHIR received the recognition for the best poster presentation for a study on myocardial insulin resistance and cardiovascular risk.

La selecció d’imatges que forma la mostra ‘L’altra mirada de la recerca’ ha estat escollida entre les millors fotografies dels 11 anys del Concurs de Fotografia Científica del Campus Vall d’Hebron.

The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention.

Identifying the common pathologies and molecular mechanisms involved in retinal and brain neurodegeneration could open up new opportunities in preventing type 2 diabetes-related cognitive impairment.

Today, 30 November, the main research lines in which both institutions will be working together are revealed.